PSA seviyesi 4-10 ng/mL olan hastalarda alt üriner sistem semptomları patoloji sonucunu ön görebilir mi?

Autor: Bilal Çelikörs, Okan Alkiş, Aykut Başer, Mehmet Murat Baykam, Hülya Yilmaz Başer, Cemil Aydin
Rok vydání: 2020
Předmět:
Zdroj: Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi. 53:81-84
ISSN: 1304-6187
DOI: 10.20492/aeahtd.747320
Popis: Objective: In this study, we aimed to investigate whether lower urinary tract symptoms are a parameter to predict prostate adenocarcinoma and bening prostatic hyperplasia in patients with a PSA level of 4-10 ng / mL. Material and Methods: 75 patients who were administered TRUS-Bx for the first time with a PSA value of 4-10 ng / ml between 01 June 2019 and 01 February 2020 were included prospectively. Age, BMI, PSA, Prostate volume, PSA density, international prostate symptom scores and international erectile function scores of the patients were recorded. According to the pathology results, patients as group 1 (bening prostatic hyperplasia) and group 2 (prostate adenocarcinoma) were divided into two groups and their relationship with the specified parameters was investigated. Results: As a result of the pathology of 75 patients who had TRUS-Bx for the first time with a PSA value of 4-10 ng / ml; Bening Prostate Hyperplasia (BPH) (group 1) was detected in 57 (76%) patients, and Prostate Adenocarcinoma (PCa) (group 2) in 18 (24%) patients. Among the parameters examined, only the stiffness in digital rectal examination finding and IPSS score low were statistically significant in Group 2 compared to group 1. In the correlation analysis, the findings were confirmed. Result: For patients with PSA 4-10 ng / mL, low IPSS score and rectal touch stiffness increase the chance of cancer detection.
Databáze: OpenAIRE